SLC12A2 and central nervous system cancer: In response to chemo reagent TMZ-mediated AVD, glioma cells upregulate NKCC1 protein to counteract against loss of intracellular K+ and Cl− and AVD (Algharabil et al., 2012; Zhu et al., 2014).